Acasti Pharma reported $2.14M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Acasti Pharma USD 2.14M 2.14M Jun/2025
Addus HomeCare USD 77.08M 3.86M Jun/2025
Amarin USD 36.57M 397K Mar/2025
Cassava Sciences USD 8.98M 23K Jun/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Option Care Health USD 170.09M 1.97M Jun/2025
Organigram Holdings CAD 25.49M 8.3M Jun/2025
Tilray USD 72.38M 4.99M Nov/2024